← Back to Search

Anti-epileptic drug

DEPAKOTE 250mg for Epilepsy (Epilepsy Trial)

Phase 1
Waitlist Available
Led By Bradley D. Vince, DO
Research Sponsored by Vince & Associates Clinical Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 2.5 months
Awards & highlights

Epilepsy Trial Summary

A study in stable epilepsy patients comparing levels of valproic acid after administration of brand and generic divalproex sodium extended release tablets.

Epilepsy Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 2.5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 2.5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depakote

Epilepsy Trial Design

2Treatment groups
Active Control
Group I: DEPAKOTE 250mgActive Control2 Interventions
Treatment B: A single 2-tablet dose of DEPAKOTE ER tablet, 250mg. Each subject will have 2 treament period with this medication and 2 treatment periods with a single 2-tablet dose of Divalproex Sodium Extended-Release 250mg tablet.
Group II: Divalproex Sodium Extended Release 250mgActive Control2 Interventions
Treatment A: A single 2-tablet dose of divalproex sodium extended-release tablet, 250mg. Each subject will have 2 treatments with this medication and two treatments with a single 2-tablet dose of DEPAKOTE 250mg tablet.

Find a Location

Who is running the clinical trial?

Vince & Associates Clinical Research, Inc.Lead Sponsor
5 Previous Clinical Trials
295 Total Patients Enrolled
Food and Drug Administration (FDA)FED
171 Previous Clinical Trials
1,331,590 Total Patients Enrolled
3 Trials studying Epilepsy
76 Patients Enrolled for Epilepsy
Bradley D. Vince, DOPrincipal InvestigatorVince & Associates Clinical Research, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
2013. "A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01898676.
All > Lgs Foundation > Epilepsy
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top